CCL Healthcare Services
Recent Blog Posts
Smart Packaging WhitePaper Smart labels for drugs and medical devices, both after commercial launch and during clinical trials, do far more than simply identify a product; their built-in intelligence provides functionality, communication capabilities, and interactivity throughout the supply chain all the way to the end user.
When it comes to CCL’s success, Stephen MacLeod, an analyst with BMO Capital Markets, points to a series of factors. “You have to take into account the company’s competitive position in the global label-making market, and its strong customer relations, [and] diverse user market,” he says. CCL’s operations span six continents and include 119 facilities, in large part the result of a series of smart acquisitions. The company’s strategy is to make small, tuck-in purchases that provide “exposure to a unique technology or a unique customer set,” notes MacLeod. But CCL has also picked up companies that operate somewhat outside its traditional line of business.